LAS VEGAS, Apr 04, 2006 (BUSINESS WIRE) -- Nutri Pharmaceuticals Research Inc. (Pink Sheets: NRPR), a developer and marketer of powdered nutritional ingredients, announced that it has appointed Farmington, Utah-based CornerStone Research and Development Inc., a consolidating entity of Mitsui & Co. (USA) Inc. and certified contract manufacturer and ingredient supplier, as the exclusive distributor for specialty O2P Powders from NPRI for the nutraceutical market.
Product quotas for the first year must total at least $750,000 and escalate each year thereafter. According to NPRI President Godfrey Yew, "CornerStone is one of the preeminent custom manufacturers of nutritional and herbal formulations in capsules, tablets and powder forms, as well as the associated packaging services required to bring these products to market. With the addition of O2P Powders, CornerStone will now be able to offer their customers and the end consumer a range of powdered bio-active products that were once only available in liquid or semi-solid form."
Nutri Pharmaceuticals Research Inc. ( www.o2p.us) provides a wide range of powdered oils for functional food, food supplement, dietary supplement, cosmetics, pet food and animal feed applications. The company has been awarded the prestigious Nutrition Business Journal "Product Merit Award" for its patent-pending O2P (TM) Powderization Process.
About CornerStone Research and Development
CornerStone Research and Development (CRD) is the one of the largest nutraceutical contract manufactures in the world with more than 120,000 square feet of space. CRD provides full turnkey product manufacturing for its clients including research, formulation, product development, blending, tableting, encapsulation, packeting, bottling, blistering, analytical testing and fulfillment. Due to its TGA certification, CRD produces products for its clients that ship to more than 22 countries around the world, including Asia, North and South America and Europe.
he words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements.